Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CD3 specific recombinant antibody

CD3 specific recombinant antibody

US Patent 6750325 · Granted Jun 15, 2004

Estimated economic value: $678,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Humanised antibodies2024
Humanised antibodies2024
Humanised antibodies2021
Humanised antibodies2021
Humanized anti-tau antibodies2018
Topical application of 1-hydroxyl-3,5-BIS(4′hydroxy styryl)benzene2014
Antibody molecules specific to human tumour necrosis factor alpha2011
CDR-grafted anti-tissue factor antibodies and methods of use thereof2010
Humanised antibodies2009
Humanised antibodies2009
CDR-grafted anti-tissue factor antibodies and methods of uses there of2009
Small molecule mimetics of erythropoietin2007